Penn team adapts CAR-T tech, reengi­neer­ing mouse cells to treat car­diac fi­bro­sis

Af­ter es­tab­lish­ing it­self as one of the pi­o­neer re­search cen­ters in the world for CAR-T can­cer ther­a­pies, cre­at­ing new at­tack ve­hi­cles to erad­i­cate can­cer cells, a team at Penn Med­i­cine has be­gun the tricky tran­si­tion of us­ing the ba­sic tech­nol­o­gy for heart re­pair work.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER